According to new research, radiation therapy administered before surgery rarely produces favorable responses in patients with ...

Ewing sarcoma is a rare, aggressive cancer that primarily strikes children and adolescents, yet it can present in infants, where it is exceptionally uncommon. U.S. registry data show an incidence of ...

A team of researchers at Mayo Clinic has discovered that using fluorescent green dye combined with imaging during surgery for soft tissue sarcoma can help surgeons determine what tissue may be at risk ...

Ewing sarcoma treatments include chemotherapy, surgery, radiation therapy, and stem cell transplants. Ewing sarcoma is a rare and aggressive cancer that typically develops in the bones or the soft ...

New research from Dartmouth Health and Dartmouth Cancer Center reveals a glowing molecule designed to highlight soft-tissue sarcomas during surgery, paving the way for more precise tumor removal and ...

A new study further supports the use of radiotherapy in the treatment of retroperitoneal sarcoma. The finding comes from two large case-control analyses of 9068 patients with localized primary ...

Synovial sarcoma is a form of soft tissue cancer. It often develops around the joints and can be difficult to diagnose. This condition can spread to other body parts, most notably the lungs. Because ...

Soft tissue sarcoma recovery extends beyond physical healing, emphasizing social engagement and emotional well-being for improved quality of life. Pain and daily activity participation are major ...

Novel biomarkers like GDF15 and OPN show promise in diagnosing and prognosticating uterine sarcoma, potentially enabling early identification and tailored therapy. Blood-based markers such as NLR and ...

Patients often don't realize they have RPS until the disease has reached an advanced stage. As a result of delayed diagnosis, surgery is the primary treatment, and these operations can be highly ...

Please provide your email address to receive an email when new articles are posted on . The addition of pembrolizumab to radiation and surgery reduced relapse risk by 43%. Results showed no ...